Anna Lantz

Karolinska University Hospital

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (6)

Martin Eklund

Associate professor

Karolinska Institutet

Alexander Valdman

Karolinska Institutet

Hari Vigneswaran

Karolinska Institutet

Lars Björnebo

Karolinska Institutet

Teja Ganta

Icahn School of Medicine at Mount Sinai

UNITED STATES

Peter Wiklund

Karolinska University Hospital

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Lantz

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (6)

Martin Eklund

Alexander Valdman

Hari Vigneswaran

Lars Björnebo

Teja Ganta

Peter Wiklund

Make your next move.

Anna Lantz

Research Interests

Explore related searches

Contact this professor

Articles (20)

Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists

MP19-10 ADDITIONAL VALUE OF MRI IN PATIENTS WITH PSA >10 NG/ML AND/OR POSITIVE DRE: IS MRI ALWAYS NEEDED?

MP49-13 INTERCENTER VARIABILITY IN THE ACCURACY OF RISK CALCULATORS BASED ON MRI PARAMETERS: EXTENSIVE EXTERNAL VALIDATION OF 7 CONTEMPORARY RISK CALCULATORS

MP74-12 IMPACT OF MAGNETIC RESONANCE IMAGING SCAN AND IMAGE ACQUISITION PROTOCOL IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER AT BIOPSY: RESULTS FROM THE PROMOD WORKING GROUP

PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT

PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM

PD57-12 PSA RESPONSE AFTER RADIOTHERAPY. IS THERE A DEFINITION OF PSA PERSISTENCE AFTER RT?

Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study.

Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.

Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer.

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up

Role of alpha- and beta-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease

Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy

Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)

Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy? - a longitudinal study

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings

Collaborators (6)

Martin Eklund

Alexander Valdman

Hari Vigneswaran

Lars Björnebo

Teja Ganta

Peter Wiklund

Make your next move.